David A. Wheeler, MD

Infectious Diseases Physicians, Inc.
Annandale, Virginia, United States

Disclosure(s): AstraZeneca: Grant/Research Support; Gilead: Grant/Research Support; Janssen: Grant/Research Support

Presentation(s):

• 155 - Long-Acting Subcutaneous Lenacapavir in People with Multi-Drug Resistant HIV-1: 3-Year Results of the CAPELLA Study

  Thursday, October 17, 2024
  2:00 PM – 2:15 PM US PT